Edgar J. Rolleman

1.4k total citations
16 papers, 1.1k citations indexed

About

Edgar J. Rolleman is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Edgar J. Rolleman has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Oncology. Recurrent topics in Edgar J. Rolleman's work include Neuroendocrine Tumor Research Advances (13 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Lung Cancer Research Studies (8 papers). Edgar J. Rolleman is often cited by papers focused on Neuroendocrine Tumor Research Advances (13 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Lung Cancer Research Studies (8 papers). Edgar J. Rolleman collaborates with scholars based in Netherlands, Switzerland and Germany. Edgar J. Rolleman's co-authors include Marion de Jong, Roelf Valkema, Bert F. Bernard, Eric P. Krenning, P.P.M. Kooij, Otto C. Boerman, Willem H. Bakker, E. P. Krenning, Marleen Melis and T. J. Visser and has published in prestigious journals such as European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine and Biology and Journal of Nuclear Medicine.

In The Last Decade

Edgar J. Rolleman

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edgar J. Rolleman Netherlands 15 695 676 593 299 158 16 1.1k
A. Srinivasan United States 13 608 0.9× 631 0.9× 610 1.0× 309 1.0× 140 0.9× 20 1.1k
Raffaella Barone Netherlands 14 792 1.1× 916 1.4× 769 1.3× 540 1.8× 205 1.3× 23 1.5k
Stefan Guhlke Germany 21 833 1.2× 720 1.1× 889 1.5× 501 1.7× 333 2.1× 55 1.6k
Arthur van Gameren Netherlands 11 435 0.6× 447 0.7× 380 0.6× 211 0.7× 79 0.5× 14 711
Jörg Schmitt Switzerland 8 623 0.9× 1.0k 1.5× 807 1.4× 541 1.8× 99 0.6× 10 1.4k
Josef Doll Germany 11 502 0.7× 273 0.4× 192 0.3× 130 0.4× 114 0.7× 13 752
Petra Kolenc Peitl Slovenia 20 526 0.8× 353 0.5× 413 0.7× 59 0.2× 110 0.7× 35 869
WH Bakker Netherlands 9 327 0.5× 583 0.9× 455 0.8× 371 1.2× 76 0.5× 16 790
Luigi Del Pozzo Switzerland 10 391 0.6× 325 0.5× 354 0.6× 133 0.4× 98 0.6× 17 629
Jan‐Erik Westlin Sweden 14 524 0.8× 283 0.4× 449 0.8× 278 0.9× 356 2.3× 36 1.1k

Countries citing papers authored by Edgar J. Rolleman

Since Specialization
Citations

This map shows the geographic impact of Edgar J. Rolleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar J. Rolleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar J. Rolleman more than expected).

Fields of papers citing papers by Edgar J. Rolleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar J. Rolleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar J. Rolleman. The network helps show where Edgar J. Rolleman may publish in the future.

Co-authorship network of co-authors of Edgar J. Rolleman

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar J. Rolleman. A scholar is included among the top collaborators of Edgar J. Rolleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar J. Rolleman. Edgar J. Rolleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Melis, Marleen, M. Visser, Mark Konijnenberg, et al.. (2009). Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours. European Journal of Nuclear Medicine and Molecular Imaging. 36(12). 1968–1976. 40 indexed citations
2.
Rolleman, Edgar J., Marleen Melis, Roelf Valkema, et al.. (2009). Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues. European Journal of Nuclear Medicine and Molecular Imaging. 37(5). 1018–1031. 94 indexed citations
3.
Bernard, Bert F., Wout A. P. Breeman, Flavio Forrer, et al.. (2008). Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats. Nuklearmedizin - NuclearMedicine. 47(3). 110–115. 40 indexed citations
4.
Forrer, Flavio, Edgar J. Rolleman, Marleen Melis, et al.. (2007). From Outside to Inside? Dose-Dependent Renal Tubular Damage After High-Dose Peptide Receptor Radionuclide Therapy in Rats Measured with In Vivo 99m Tc-DMSA-SPECT and Molecular Imaging. Cancer Biotherapy and Radiopharmaceuticals. 22(1). 40–49. 26 indexed citations
5.
Gotthardt, Martin, Wim J.G. Oyen, Marion de Jong, et al.. (2007). Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides. Journal of Nuclear Medicine. 48(4). 596–601. 138 indexed citations
6.
Melis, Marleen, Eric P. Krenning, Bert F. Bernard, et al.. (2007). Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences. Nuclear Medicine and Biology. 34(6). 633–641. 54 indexed citations
7.
Rolleman, Edgar J., P.P.M. Kooij, Wouter W. de Herder, et al.. (2007). Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney. European Journal of Nuclear Medicine and Molecular Imaging. 34(11). 1854–1860. 36 indexed citations
8.
Rolleman, Edgar J., Flavio Forrer, Bert F. Bernard, et al.. (2006). Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate. European Journal of Nuclear Medicine and Molecular Imaging. 34(5). 763–771. 36 indexed citations
9.
Rolleman, Edgar J., Eric P. Krenning, Bert F. Bernard, et al.. (2006). Long-term toxicity of [177Lu-DOTA0,Tyr3]octreotate in rats. European Journal of Nuclear Medicine and Molecular Imaging. 34(2). 219–227. 46 indexed citations
10.
Forrer, Flavio, Roelf Valkema, Bert F. Bernard, et al.. (2006). In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals. European Journal of Nuclear Medicine and Molecular Imaging. 33(10). 1214–1217. 45 indexed citations
11.
Rolleman, Edgar J., Eric P. Krenning, Arthur van Gameren, Bert F. Bernard, & Marion de Jong. (2004). Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructose.. PubMed. 45(4). 709–13. 29 indexed citations
12.
Rolleman, Edgar J., et al.. (2003). Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine. European Journal of Nuclear Medicine and Molecular Imaging. 30(1). 9–15. 256 indexed citations
13.
Breeman, Wout A. P., Marion de Jong, Bert F. Bernard, et al.. (1997). Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in rats. Nuclear Medicine and Biology. 24(8). 749–753. 6 indexed citations
14.
Bernard, Bert F., E. P. Krenning, Wout A. P. Breeman, et al.. (1997). D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.. PubMed. 38(12). 1929–33. 112 indexed citations
15.
Jong, Marion de, Edgar J. Rolleman, Bert F. Bernard, et al.. (1996). Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.. PubMed. 37(8). 1388–92. 109 indexed citations
16.
Jong, Marion de, Wout A. P. Breeman, Bert F. Bernard, et al.. (1995). Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 22(7). 608–616. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Srinivasan Breakdown of academic impact, for papers by Raffaella Barone Breakdown of academic impact, for papers by Stefan Guhlke Breakdown of academic impact, for papers by Arthur van Gameren Breakdown of academic impact, for papers by Jörg Schmitt Breakdown of academic impact, for papers by Josef Doll Breakdown of academic impact, for papers by Petra Kolenc Peitl Breakdown of academic impact, for papers by WH Bakker Breakdown of academic impact, for papers by Luigi Del Pozzo Breakdown of academic impact, for papers by Jan‐Erik Westlin
Rankless by CCL
2026